Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development

Developmental Dynamics

Volumn 232, Issue 2, 2005, Pages 399-407

  Rychkova, Natalia ^a   Stahl, Sonja ^a   Gaetzner, Sabine ^a   Felbor, Ute ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Brain and eye development; Collagen XVIII; Endostatin; Heparan sulfate; Knobloch syndrome; Vascular endothelial growth factor

Indexed keywords

ALKALINE PHOSPHATASE FUSION PROTEIN; COLLAGEN TYPE 15; COLLAGEN TYPE 18; ENDOSTATIN; HEPARAN SULFATE; HYBRID PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ECTODERM; EMBRYO DEVELOPMENT; EYE DEVELOPMENT; EYE DISEASE; FOREBRAIN; GENE DELETION; KNOBLOCH SYNDROME; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OLIGOMERIZATION; OPTIC NERVE; PHENOTYPE; PRIORITY JOURNAL; RHOMBENCEPHALON; SKULL DEFECT; TUMOR GROWTH;

ALKALINE PHOSPHATASE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; BRAIN; COLLAGEN; COLLAGEN TYPE XVIII; CORNEA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOSTATINS; EYE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; HEPARITIN SULFATE; HUMANS; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; PHENOTYPE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 12344252742     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.20222     Document Type: Article

References (42)

1. Ackley BD, Crew JR, Elamaa H, Pihlajaniemi T, Kuo CJ, Kramer JM. 2001. The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance. J Cell Biol 152:1219-1232.
2. Bhutto IA, Kim SY, McLeod DS, Merges C, Fukai N, Olsen BR, Lutty GA. 2004. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 45:1544-1552.
3. Chang Z, Choon A, Friedl A. 1999. Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding. Am J Pathol 155:71-76.
4. Cook GR, Knobloch WH. 1982. Autosomal recessive vitreoretinopathy and encephaloceles. Am J Ophthalmol 94:18-25.
5. Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engström Å, Timpl R, Welsh M, Claesson-Welsh L. 2000. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95:3403-3411.
6. Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W. 2000. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 19:1187-1194.
7. Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaissé J-M. 2000. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486:247-251.
8. Flanagan JG, Cheng H-J, Feldheim DA, Hattori M, Lu Q, Vanderhaeghen P. 2000. Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Methods Enzymol 327:19-35.
9. Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L, Niemelä M, Ilves M, Li E, Pihlajaniemi T, Olsen BR. 2002. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J 21:1535-1544.
10. Gaetzner S, Deckers MML, Stahl S, Löwik C, Olsen BR, Felbor U. 2005. Endostatin's heparin sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone expiants. Matrix Biol (in press).
11. Hohenester E, Sasaki T, Olsen BR, Timpl R. 1998. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution. EMBO J 17:1656-1664.
12. Javaherian K, Park SY, Pickl WF, LaMontagne KR, Sjin RTT, Gillies S, Lo KM. 2002. Laminin modulates morphogenic properties of the collagen XVIII endostatin domain. J Biol Chem 277:45211-45218.
13. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R, Zeng H, Mukhopadhyay D, Chen RL, Lander AD, Hagihara K, Yamaguchi Y, Sasisekharan R, Cantley L, Sukhatme VP. 2001. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 7:811-822.
14. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N. 1996. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271:7788-7795.
15. Kliemann SE, Waetge RTL, Suzuki OT, Passos-Bueno MR, Rosemberg S. 2003. Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families. Am J Med Genet 119A:15-19.
16. Knobloch WH, Layer JM. 1971. Retinal detachment and encephalocele. J Pediatr Ophthalmol 8:181-184.
17. Kreuger J, Matsumoto T, Vanwildemeersch M, Sasaki T, Timpl R, Claesson-Welsh L, Spillmann D, Lindahl U. 2002. Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J 21:6303-6311.
18. Marneros AG, Olsen BR. 2003. Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome. Invest Ophthalmol Vis Sci 44:2367-2372.
19. Marneros AG, Keene DR, Hansen U, Fukai N, Moulton K, Goletz PL, Moiseyev G, Pawlyk BS, Halfter W, Dong S, Shibata M, Li T, Crouch RK, Bruckner P, Olsen BR. 2004. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J 23:89-99.
20. Menzel O, Bekkeheien RCJ, Reymond A, Fukai N, Boye E, Kosztolanyi G, Aftimos S, Deutsch S, Scott HS, Olsen BR, Antonarakis SE, Guipponi M. 2004. Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum Mutat 23:77-84.
21. Muona A, Eklund L, Väisänen T, Pihlajaniemi T. 2002. Developmentally regulated expression of type XV collagen correlates with abnormalities in Col15a1-/- mice. Matrix Biol 21:89-102.
22. Ng Y-S, Rohan R, Sunday ME, Demello DE, D'Amore PA. 2001. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 220:112-121.
23. Ogunshola OO, Antic A, Donoghue MJ, Fan S-Y, Kim H, Stewart WB, Madri JA, Ment LR. 2002. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 277:11410-11415.
24. Oh SP, Kamagata Y, Muragaki Y, Timmons S, Ooshima A, Olsen BR. 1994. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc Natl Acad Sci U S A 91:4229-4233.
25. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285
26. Rathjen PD, Toth S, Willis A, Heath JK, Smith AG. 1990. Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell 62:1105-1114.
27. Rehn M, Hintikka E, Pihlajaniemi T. 1996. Characterization of the mouse gene for the alpha 1 chain of type XVIII collagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters. Genomics 32:436-446.
28. Ricard-Blum S, Feraud O, Lortat-Jacob H, Rencurosi A, Fukai N, Dkhissi F, Vittet D, Imberty A, Olsen BR, van der Rest M. 2004. Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations. J Biol Chem 279:2927-2936.
29. Robinson GS, Ju M, Shih S-C, Xu X, McMahon G, Caldwell RB, Smith LEH. 2001. Nonvascular role for VEGF: V1EGFR-1, 2 activity is critical for neural retinal development. FASEB J 15:1215-1217.
30. Sasaki T, Fukai N, Mann K, Göhring W, Olsen BR, Timpl R. 1998. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J 17:4249-4256.
31. Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U, Hohenester E, Timpl R. 1999. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J 18:6240-6248.
32. Sasaki T, Larsson H, Tisi D, Claesson-Welsh L, Hohenester E, Timpl R. 2000. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol 301:1179-1190.
33. Schmidt A, Wenzel D, Ferring I, Kazemi S, Sasaki T, Hescheler J, Timpl R, Addicks K, Fleischmann BK, Bloch W. 2004. Influence of endostatin on embryonic vasculo- and angiogenesis. Dev Dyn 230:468-480.
34. Sertié AL, Sossi V, Camargo AA, Zatz M, Brahe C, Passos-Bueno MR. 2000. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum Mol Genet 9:2051-2058.
35. Shalaby F, Ho J, Stanford WL, Fischer K-D, Schuh AC, Schwartz L, Bernstein A, Rossant J. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981-990.
36. Snitkovsky S, Niederman TMJ, Mulligan RC, Young JAT. 2001. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. J Virol 75:1571-1575.
37. Suzuki OT, Sertié AL, Der Kaloustian VM, Kok F, Carpenter M, Murray J, Czeizel AE, Kliemann SE, Rosemberg S, Monteiro M, Olsen BR, Passos-Bueno MR. 2002. Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am J Hum Genet 71:1320-1329.
38. Wen W, Moses MA, Wiederschain D, Arbiser JL, Folkman J. 1999. The generation of endostatin is mediated by elastase. Cancer Res 59:6052-6056.
39. Wickström SA, Alitalo K, Keski-Oja J. 2003. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J Biol Chem 278:37895-37901.
40. Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Löwik C, Timpl R, Olsen BR. 1999. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18:4414-4423.
41. Ylikärppä R, Eklund L, Sormunen R, Kontiola AI, Utriainen A, Määttä M, Fukai N, Olsen BR, Pihlajaniemi T. 2003a. Lack of type XVIII collagen results in anterior ocular defects. FASEB J 17:2257-2259.
42. Ylikärppä R, Eklund L, Sormunen R, Muona A, Fukai N, Olsen BR, Pihlajaniemi T. 2003b. Double knockout mice reveal a lack of major functional compensation between collagens XV and XVIII. Matrix Biol 22:443-448.